Rate of Complete Symptom Relief, Prevention of Symptom Relapse: Grades A and B Esophagitis of Esomeprazole Therapy
Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
To investigate the impact of initial treatment duration (4-week versus 8-week)of Esomeprazole
(40mg) on the rate of symptom relapse and sustained healing of esophagitis in patients with
symptomatic erosive esophagitis